GH3.2 Antibody

Shipped with Ice Packs
In Stock

Description

GHin Plant Biochemistry

The GH3 (Gretchen Hagen 3) family of proteins in plants includes PpGH3.2 (from Physcomitrium patens), an enzyme involved in conjugating auxins like indole-3-acetic acid (IAA) and synthetic compounds such as 2,4-dichlorophenoxyacetic acid (2,4-D) to amino acids. This protein is not an antibody but a metabolic enzyme with substrate specificity:

GH3 ProteinAmino Acid SubstrateAcyl SubstrateActivity (k<sub>cat</sub>/K<sub>m</sub>, min⁻¹ mM⁻¹)
PpGH3.2AspIAAInactive
PpGH3.2GluIAA6.8
PpGH3.2Asp2,4-D1.0
PpGH3.2Glu2,4-DInactive

Key findings:

  • PpGH3.2 exhibits weak enzymatic activity compared to other GH3 proteins (e.g., PtGH3.6 or SbGH3.11) .

  • It shows no activity with jasmonic acid (JA) or 4-hydroxybenzoic acid (4-HBA) .

GH3 in Immunoglobulin G (IgG) Subclass Research

The term IgG3 (a human antibody subclass) is frequently studied for its unique structural and functional properties. While not directly related to "GH3.2," IgG3 antibodies have distinct features:

Example Data: IgG3 vs. IgG1 in Viral Neutralization

Antibody (mAb)SubclassH3N2/2016 Neutralization IC<sub>90</sub> (nM)SARS-CoV-2 NT<sub>100</sub> (nM)
10053–1G05IgG1≥1,200295.88
10053–1G05IgG366.85.91
H4IgG3N/A5.91

Key findings:

  • IgG3’s elongated hinge improves binding avidity to low-density viral spikes (e.g., SARS-CoV-2) .

  • IgG3 neutralizes drifted influenza strains (e.g., H3N2/2016) 18-fold more effectively than IgG1 .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
GH3.2 antibody; BRU6 antibody; CF4 antibody; YDK1 antibody; At4g37390 antibody; F6G17.40Indole-3-acetic acid-amido synthetase GH3.2 antibody; EC 6.3.2.- antibody; Auxin-responsive GH3-like protein 2 antibody; AtGH3-2 antibody; Protein YADOKARI 1 antibody
Target Names
GH3.2
Uniprot No.

Target Background

Function
GH3.2 Antibody catalyzes the synthesis of indole-3-acetic acid (IAA)-amino acid conjugates, providing a mechanism for the plant to manage excess auxin levels. It exhibits strong reactivity with Glu, Gln, Trp, Asp, Ala, Leu, Phe, Gly, Tyr, Met, Ile, and Val. Minimal or no product formation is observed with His, Ser, Thr, Arg, Lys, or Cys. The enzyme is also active on pyruvic and butyric acid analogs of IAA, PAA, and the synthetic auxin naphthaleneacetic acid (NAA). Notably, the two chlorinated synthetic auxin herbicides 2,4-D and 3,6-dichloro-o-anisic acid (dicamba) are not suitable substrates for this enzyme.
Database Links

KEGG: ath:AT4G37390

STRING: 3702.AT4G37390.1

UniGene: At.23361

Protein Families
IAA-amido conjugating enzyme family
Tissue Specificity
Expressed in flowers, pollen, cotyledons, stipules, true leaves, hypocotyls, and all parts of the roots except for the primary root tips.

Q&A

How to validate GH3.2 antibody specificity in plant hormone signaling studies?

Methodology:

  • Perform Western blotting using Arabidopsis thaliana wild-type and gh3.2 knockout mutants to confirm antibody specificity (expected band at ~68 kDa) .

  • Use immunofluorescence with tissue-specific overexpression lines (e.g., root or leaf tissues) to verify subcellular localization patterns (nuclear envelope or cytoplasm) .

  • Include peptide competition assays by pre-incubating the antibody with the immunogen peptide (19-amino acid sequence near the N-terminus) to confirm signal loss .

What experimental controls are essential for GH3.2 functional studies in auxin homeostasis?

  • Negative controls:

    • gh3.2 T-DNA insertion mutants .

    • Non-transgenic wild-type plants treated with auxin biosynthesis inhibitors (e.g., yucasin) .

  • Positive controls:

    • Tissue from GH3.2 overexpression lines under stress conditions (e.g., pathogen infection) .

    • Samples treated with exogenous indole-3-butyric acid (IBA) to induce GH3.2 activity .

How to resolve contradictions in GH3.2’s dual roles in salicylic acid (SA) and auxin signaling?

Experimental design:

  • Conduct time-course transcriptomics after pathogen inoculation (Pseudomonas syringae) to compare SA-responsive (PR-1) and auxin-responsive (Aux/IAA) gene expression in gh3.2 mutants .

  • Use radiolabeled SA/IAA adenylation assays to quantify GH3.2’s substrate preference (15-fold catalytic efficiency difference between IBA and IAA observed in GH3.15 homologs) .

Data interpretation framework:

ConditionSA AccumulationFree IAA LevelsPR-1 Expression
Wild typeHighLowUpregulated
gh3.2 mutantReducedElevatedSuppressed
GH3.2 overexpressionVery highVery lowHyper-upregulated

Source: Adapted from .

What structural features of GH3.2 influence its substrate specificity?

Methodology:

  • Perform site-directed mutagenesis targeting conserved residues in the acyl acid-binding pocket (e.g., Tyr^267 and Asp^319 in GH3.15) .

  • Analyze kinetic parameters (k<sub>cat</sub>/K<sub>m</sub>) using IAA, IBA, and JA substrates via HPLC-MS .

Key findings from homologs:

Residue MutationSubstrate (IAA)Substrate (IBA)Catalytic Efficiency (% WT)
Wild type1.015.0100
Y267F0.32.114
D319A0.80.96

Data extrapolated from GH3.15 studies .

How to optimize GH3.2 immunoprecipitation for interaction partner identification?

  • Use crosslinkers (e.g., DSP) to stabilize transient interactions during pathogen-induced stress .

  • Combine size-exclusion chromatography with co-IP to isolate GH3.2 complexes >500 kDa .

  • Validate hits using bimolecular fluorescence complementation (BiFC) in Nicotiana benthamiana .

What metrics indicate GH3.2 antibody lot-to-llot variability?

  • Lot consistency tests:

    • Batch-specific EC<sub>50</sub> in ELISA (target ≤10% CV) .

    • Signal-to-noise ratio in Western blots (recommended ≥5:1) .

    • Immunofluorescence intensity in standardized tissue sections (e.g., Arabidopsis root tips) .

Can GH3.2 activity modulate cross-talk between jasmonate and auxin pathways?

Approach:

  • Profile JA-Ile conjugates and free IAA levels in gh3.2 mutants under herbivory stress using LC-MS/MS .

  • Compare transcript levels of JAZ repressors and ARF activators via qRT-PCR .

How to engineer GH3.2 for synthetic biology applications?

  • Design CDR-H3 variants with extended length (12–13 residues) to enhance hot spot residues for antigen binding .

  • Use yeast surface display to screen for mutants with altered substrate specificity (e.g., preferential SA conjugation) .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.